Halley Tsai, MD
Pulmonary Disease · Honolulu
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 23
- 5 carriers
- Offices
- 2
Offices
2 locations · Queens University Medical Group · 614 clinicians in this group
Looking this up.
Hospitals listed: The Queens Medical Center. That is not proof they admit you there this week.
Plans that list them
23 plans · 5 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Tsai’s office at (808) 521-8913 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
23 of 23 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A126277 · Current
Licensed to practise in California · since 2013 · expires 2026-11-30 · Albert Einstein College of Medicine of Yeshiva University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- The Queens Medical CenterHonolulu, HIAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of The Queens Health Systems, which runs 4 hospitalsPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 3 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.34 (1.12 to 1.55), Jul 2022 – Jun 2024Worse than the national rate — Iatrogenic pneumothorax rate: 0.47 (0.29 to 0.65) · 11,638 cases, Jul 2022 – Jun 2024Worse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.32 (3.74 to 6.9) · 3,569 cases, Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.79 (1.36 to 2.23) · 10,444 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.453, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.427, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.345, Oct 2024 – Sep 2025
See every measure and the patient survey for The Queens Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 3 better, 3 the same, 2 worse of 8 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.34 (1.12 to 1.55) | Worse | Jul 2022 – Jun 2024 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.47 (0.29 to 0.65) · 11,638 cases | Worse | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.32 (3.74 to 6.9) · 3,569 cases | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.79 (1.36 to 2.23) · 10,444 cases | Worse | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.453 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.427 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.345 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0.12 to 1.78) · 2,583 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 181.61 (147.16 to 216.07) · 200 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.6 · 101 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 130 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.3 · 266 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 619 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.3 · 815 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 1,115 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 7,459 cases | None | Jul 2024 – Jun 2025 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.11 to 0.45) · 12,099 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.17 (0 to 2.44) · 1,411 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.9 (1.73 to 4.06) · 3,175 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.07 (2.95 to 11.2) · 1,400 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.22 (1.54 to 6.91) · 1,481 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.45 (0.06 to 2.83) · 821 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 163 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.751 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.143 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 501 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.2 · 1,438 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 10.8 · 272 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -5 · 698 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 15.4 · 799 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.4 · 1,657 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.6 (5.1 to 8.6) · 477 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.2 (9.1 to 13.9) · 477 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 171 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.4 · 122 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 17.5 · 353 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.6 (10 to 16.1) · 2,546 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 768 cases | No different | Jan 2024 – Dec 2024 |
What patients said (3,104 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 73% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 52% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$10,134
Medicare paid this office $10,134 for 93 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (30+ min) | 59 | $5,466 | $93 |
| New patient visit (45+ min) | 11 | $1,448 | $132 |
Who their Medicare patients are
93 Original Medicare patients in 2024. Average age 75 · Women 43% · Health risk score 1.37. At or below the middle of the specialty; the typical pulmonary disease clinician is at 2.13.
Conditions among them: High blood pressure 75% · Diabetes 45% · Coronary heart disease 41% · Chronic kidney disease 40% · Heart failure 25% · COPD 20% · Atrial fibrillation 18% · Cancer 13% · Depression 13%.
The office billed $32,585, Medicare allowed $12,918 and paid $10,134; for 123 services of 16 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 93 | 123 | 75 | 1.37 | $32,585 | $10,134 |
| 2023 | 285 | 529 | 71 | 2.24 | $580,677 | $57,975 |
| 2022 | 237 | 440 | 70 | 1.93 | $486,608 | $54,916 |
| 2021 | 282 | 474 | 70 | 2.15 | $511,738 | $49,533 |
| 2020 | 283 | 569 | 70 | 2.55 | $692,352 | $70,676 |
| 2019 | 90 | 150 | 68 | 2.84 | $161,304 | $17,388 |
| 2018 | 32 | 38 | 69 | 2.68 | $35,544 | $3,774 |
| 2017 | 17 | 18 | 66 | 2.18 | $8,134 | $986 |
| 2015 | 31 | 95 | 71 | 2.80 | $24,902 | $6,287 |
| 2014 | 20 | 49 | 69 | 3.13 | $13,724 | $3,530 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Critical care, first 30-74 minutes | 67 | $30,815 | $198 |
| Short return visit (20+ min) | 140 | $9,808 | $52 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $7,117 | $174 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 35 | $4,937 | $112 |
| Return visit (30+ min) | 12 | $1,084 | $77 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $793 | $53 |
2022: 8 services
| Critical care, first 30-74 minutes | 50 | $33,938 | $236 |
| Short return visit (20+ min) | 95 | $6,682 | $57 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $4,053 | $225 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $1,935 | $108 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $1,801 | $72 |
| Telephone medical discussion with physician, 21-30 minutes | 17 | $1,396 | $78 |
| Telephone medical discussion with physician, 11-20 minutes | 16 | $1,014 | $60 |
| Short return visit | 14 | $366 | $26 |
2021: 9 services
| Critical care, first 30-74 minutes | 50 | $27,775 | $220 |
| Short return visit (20+ min) | 79 | $5,711 | $60 |
| Telephone medical discussion with physician, 11-20 minutes | 54 | $4,251 | $61 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 14 | $1,658 | $111 |
| Telephone medical discussion with physician, 21-30 minutes | 16 | $1,317 | $77 |
| Return visit (30+ min) | 11 | $1,023 | $93 |
| Telephone medical discussion with physician, 5-10 minutes | 27 | $872 | $30 |
| Sleep study including heart rate, breathing, airflow, and effort | 24 | $758 | $32 |
| Short return visit | 11 | $352 | $32 |
2020: 10 services
| Critical care, first 30-74 minutes | 74 | $49,492 | $229 |
| Telephone medical discussion with physician, 21-30 minutes | 49 | $3,727 | $72 |
| Telephone medical discussion with physician, 11-20 minutes | 78 | $3,700 | $39 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $2,972 | $110 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $2,045 | $76 |
| Return visit (30+ min) | 24 | $1,891 | $76 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 17 | $1,754 | $103 |
| Short return visit (20+ min) | 33 | $1,102 | $31 |
| Sleep study in sleep lab (6 years or older) | 11 | $1,055 | $96 |
| Sleep study including heart rate, breathing, airflow, and effort | 13 | $537 | $41 |
2019: 3 services
| Critical care, first 30-74 minutes | 35 | $13,122 | $199 |
| Short return visit (20+ min) | 22 | $961 | $44 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 11 | $918 | $83 |
2018: 1 service
| Short return visit (20+ min) | 13 | $446 | $34 |
2015: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $2,494 | $64 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,566 | $120 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 13 | $928 | $34 |
Medicaid work
$1,327 in 2024
Medicaid paid $1,327 for 59 billed services this clinician did in 2024, up to 16 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (30+ min) | 12 | $1,327 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 16 | $0 |
| Blood pressure has a systolic value of < 140 and a diastolic value of < 90 | 16 | $0 |
| Documentation that patient is a current non-tobacco user | 15 | $0 |
| 2024 | 59 | 4 | 16 | $1,327 |
| 2023 | 2,265 | 17 | 103 | $22,465 |
| 2022 | 860 | 5 | 113 | $8,798 |
| 2021 | 651 | 4 | 44 | $15,630 |
| 2020 | 314 | 3 | 37 | $11,760 |
| 2019 | 97 | 2 | 23 | $3,915 |
See the largest Medicaid services in earlier years
2023
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 353 | $14,565 |
| Short return visit (20+ min) | 964 | $3,845 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 340 | $2,906 |
| IP/OBS CONSLTJ NEW/EST PT HIGH MDM 80 MINUTES | 24 | $686 |
| Polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep, attended by a technologist | 13 | $197 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 33 | $82 |
| Diffusing capacity | 36 | $57 |
| Short return visit | 29 | $47 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 16 | $41 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 12 | $33 |
| Sleep study, unattended, simultaneous recording of, heart rate, oxygen saturation, respiratory airflow, and respiratory effort (eg, thoracoabdominal movement) | 32 | $6 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 94 | $0 |
2022
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 162 | $5,904 |
| Short return visit (20+ min) | 563 | $2,392 |
| Short return visit | 106 | $388 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 15 | $68 |
| Diffusing capacity | 14 | $45 |
2021
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 322 | $14,820 |
| Short return visit (20+ min) | 192 | $681 |
| Short return visit | 124 | $121 |
| Diffusing capacity | 13 | $7 |
2020
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 208 | $11,526 |
| Short return visit (20+ min) | 92 | $234 |
| Return visit (30+ min) | 14 | $0 |
2019
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 78 | $3,756 |
| Short return visit (20+ min) | 19 | $159 |
Drugs they prescribed that Part D paid
$189,457
Pharmacies billed $189,457 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 413) in 2024. At or below the middle of the specialty; the typical pulmonary disease clinician is at 0%.
140 generic and 273 brand-name prescriptions · $189,457 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ambrisentan | 20 | $43,876 | $2,194 |
| Incruse Ellipta | 35 | $12,526 | $358 |
| Spiriva Handihaler | 13 | $10,644 | $819 |
| Spiriva Respimat | 11 | $5,555 | $505 |
| Fluticasone-Salmeterol | 11 | $5,342 | $486 |
See all 13 drugs
| Ambrisentan | 20 | $43,876 | $2,194 |
| Incruse Ellipta | 35 | $12,526 | $358 |
| Spiriva Handihaler | 13 | $10,644 | $819 |
| Spiriva Respimat | 11 | $5,555 | $505 |
| Fluticasone-Salmeterol | 11 | $5,342 | $486 |
| Advair Hfa | 19 | $5,331 | $281 |
| Albuterol Sulfate Hfa | 76 | $3,417 | $45 |
| Symbicort | 14 | $3,219 | $230 |
| Wixela Inhub | 14 | $2,054 | $147 |
| Ventolin Hfa | 22 | $1,178 | $54 |
| Fluticasone Propionate | 33 | $440 | $13 |
| Montelukast | 24 | $360 | $15 |
| Omeprazole | 14 | $187 | $13 |
Year by year
| 2024 | 413 | 88 | 0% (0) | 66% | $189,457 |
| 2023 | 984 | 133 | 0% (0) | 67% | $415,059 |
| 2022 | 922 | 139 | 0% (0) | 76% | $449,394 |
| 2021 | 866 | 126 | 0% (0) | 74% | $245,872 |
| 2020 | 517 | 105 | 0% (0) | 66% | $130,447 |
| 2019 | 29 | 18 | 0% (0) | 59% | $5,140 |
| 2018 | 87 | 22 | None | 79% | $16,706 |
| 2017 | 39 | 13 | 0% (0) | 85% | $8,968 |
| 2016 | 32 | None | 0% (0) | 84% | $6,940 |
| 2015 | 100 | 26 | None | None | $5,167 |
| 2014 | 64 | 19 | 0% (0) | None | $2,443 |
| 2013 | 16 | None | 0% (0) | None | $350 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 21 drugs
| Ambrisentan | 23 | $58,080 | $2,525 |
| Spiriva Handihaler | 72 | $56,934 | $791 |
| Dupixent | 14 | $55,763 | $3,983 |
| Advair Diskus | 88 | $51,226 | $582 |
| Symbicort | 74 | $37,601 | $508 |
| Incruse Ellipta | 51 | $23,253 | $456 |
| Spiriva Respimat | 26 | $11,841 | $455 |
| Atrovent Hfa | 13 | $8,737 | $672 |
| Ventolin Hfa | 92 | $6,532 | $71 |
| Albuterol Sulfate Hfa | 120 | $6,207 | $52 |
| Breo Ellipta | 13 | $5,996 | $461 |
| Flovent Hfa | 17 | $4,856 | $286 |
| Sildenafil Citrate | 27 | $4,388 | $163 |
| Qvar Redihaler | 12 | $3,236 | $270 |
| Wixela Inhub | 13 | $2,914 | $224 |
| Montelukast | 53 | $974 | $18 |
| Fluticasone Propionate | 54 | $858 | $16 |
| Omeprazole | 17 | $243 | $14 |
| Prednisone | 33 | $222 | $7 |
| Azithromycin | 16 | $162 | $10 |
| Furosemide | 20 | $149 | $7 |
2022: 19 drugs
| Ofev | 12 | $149,834 | $12,486 |
| Spiriva Handihaler | 101 | $54,629 | $541 |
| Dupixent | 13 | $47,037 | $3,618 |
| Advair Diskus | 79 | $41,441 | $525 |
| Symbicort | 95 | $37,889 | $399 |
| Incruse Ellipta | 36 | $15,217 | $423 |
| Advair Hfa | 23 | $12,539 | $545 |
| Atrovent Hfa | 23 | $11,243 | $489 |
| Albuterol Sulfate Hfa | 137 | $7,369 | $54 |
| Spiriva Respimat | 13 | $5,856 | $450 |
| Breo Ellipta | 15 | $4,685 | $312 |
| Ventolin Hfa | 74 | $3,896 | $53 |
| Wixela Inhub | 11 | $1,874 | $170 |
| Montelukast | 41 | $1,262 | $31 |
| Water | 12 | $963 | $80 |
| Fluticasone Propionate | 44 | $507 | $12 |
| Azithromycin | 11 | $467 | $42 |
| Prednisone | 35 | $332 | $9 |
| Pantoprazole | 14 | $167 | $12 |
2021: 16 drugs
| Spiriva | 108 | $51,505 | $477 |
| Dupixent | 13 | $39,130 | $3,010 |
| Advair Diskus | 69 | $38,313 | $555 |
| Symbicort | 94 | $35,742 | $380 |
| Incruse Ellipta | 29 | $17,036 | $587 |
| Advair Hfa | 31 | $14,952 | $482 |
| Breo Ellipta | 16 | $8,225 | $514 |
| Ventolin Hfa | 98 | $5,892 | $60 |
| Spiriva Respimat | 15 | $5,502 | $367 |
| Albuterol Sulfate Hfa | 104 | $5,237 | $50 |
| Pulmicort Flexhaler | 19 | $5,037 | $265 |
| Montelukast | 54 | $870 | $16 |
| Fluticasone Propionate | 46 | $399 | $9 |
| Omeprazole | 29 | $341 | $12 |
| Prednisone | 17 | $241 | $14 |
| Pantoprazole | 12 | $221 | $18 |
2020: 13 drugs
| Advair Diskus | 38 | $21,524 | $566 |
| Spiriva | 42 | $20,292 | $483 |
| Symbicort | 48 | $17,420 | $363 |
| Incruse Ellipta | 18 | $7,689 | $427 |
| Ventolin Hfa | 67 | $4,882 | $73 |
| Atrovent Hfa | 11 | $4,309 | $392 |
| Itraconazole | 11 | $2,743 | $249 |
| Albuterol Sulfate Hfa | 44 | $2,531 | $58 |
| Fluticasone Propionate | 27 | $368 | $14 |
| Pantoprazole | 18 | $245 | $14 |
| Montelukast | 23 | $202 | $9 |
| Prednisone | 28 | $199 | $7 |
| Omeprazole | 12 | $64 | $5 |
2018: 3 drugs
| Symbicort | 18 | $5,866 | $326 |
| Incruse Ellipta | 11 | $3,604 | $328 |
| Ventolin Hfa | 20 | $1,343 | $67 |
Money from drug and device companies
$207 in 2025
| 2025 | 5 | 8 | None | $207 |
| 2024 | 1 | 1 | None | $18 |
| 2023 | 1 | 1 | None | $31 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Insmed | Arikayce | $92 | 3 payments
|
| Baxter Healthcare | Hillrom - Vest System Model 105 Home Care | $40 | 2 payments
|
| Harmony Biosciences | Wakix | $38 | 1 payment
|
| GlaxoSmithKline | Trelegy Ellipta | $23 | 1 payment
|
| Lilly USA | Mounjaro | $14 | 1 payment
|
See all 8 published payments
| GlaxoSmithKline | Meals · 2025-11-10 | Trelegy Ellipta | $23 |
| Insmed | Meals · 2025-10-17 | Arikayce | $34 |
| Insmed | Meals · 2025-09-05 | Arikayce | $32 |
| Baxter Healthcare | Meals · 2025-07-09 | Hillrom - Vest System Model 105 Home Care | $15 |
| Harmony Biosciences | Meals · 2025-05-21 | Wakix | $38 |
| Baxter Healthcare | Meals · 2025-04-17 | Hillrom - Vest System Model 105 Home Care | $25 |
| Lilly USA | Meals · 2025-04-04 | Mounjaro | $14 |
| Insmed | Meals · 2025-01-17 | Arikayce | $26 |
See earlier years (2024, 2023)
2024: $18
| Philips North America | (8874) Incourage | $18 | 1 payment
|
2023: $31
| Erbe USA | Erbe Vio3 | $31 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1518250653
- Licence
- CA A126277California A126277: Current · expires 2026-11-30
- Trained
- Albert Einstein College of Medicine of Yeshiva University, 2011
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RP1001X (207RP1001X); Internal medicine (207R00000X); Federal specialty code 207RS0012X (207RS0012X)
- Mailing address
- 1329 Lusitana St Ste 704, Honolulu, HI, 96813
- NPI first listed
- 2011-05-23
- NPI last updated
- 2024-10-03
- NPI record certified
- 2024-10-03
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 751 S Bascom Ave, San Jose, CA, 95128